Faruqi & Faruqi, LLP Encourages Investors Who Suffered

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in IRadimed Corporation (IRMD) to Contact the Firm

NEW YORK, NY --(Marketwired - September 12, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in IRadimed Corporation ("IRadimed" or the "Company") ( NASDAQ : IRMD ) of the November 10, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against IRadimed and certain executives.

A complaint has been filed in the United States District Court for the Southern District of Florida on behalf of all persons who purchased IRadimed securities between July 15, 2014 and September 2, 2014, inclusive (the "Class Period").

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

Specifically, the action alleges that during the Class Period, IRadimed made false and/or misleading statements and/or failed to disclose that: (i) the Company considerably modified its IV infusion pump system, which could substantially affect the safety and/or effectiveness of the devices; (ii) the mRidium 3860+ infusion pump requires individual FDA clearance; and (iii) as a result, under applicable federal regulations IRadimed's infusion pumps are "adulterated" and "misbranded."

On September 2, 2014, the Company announced that the FDA had sent a warning letter related to an inspection of the Company's facility. The warning letter requests that the Company immediately terminate activities that result in the misbranding or adulteration of the mRidium 3860 MRI infusion pump, mRidium 3850 MRI infusion pump, and the mRidium 3860+ MRI infusion pump.

Following this news, the price of IRadimed stock declined by $3.25 per share, or over 31%, to close on September 3, 2014 at $7.15 per share.

Request more information now by clicking here:  www.faruqilaw.com/ IRMD. There is no cost or obligation to you.

Take Action

If you invested in IRadimed securities between July 15, 2014 and September 2, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/IRMD . You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com . Faruqi & Faruqi, LLP also encourages anyone with information regarding IRadimed's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw .

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP 369 Lexington Avenue, 10th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. rgonnello@faruqilaw.com Telephone: (877) 247-4292 or (212) 983-9330

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 231

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 445

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 155

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 212

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 190

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Growth Stocks to Consider: Nvidia, Super Micro, Royal Caribbean

Updated Category News Views 255

Exploring High-Performing Stocks After the Pandemic Following the pandemic, the stock market has experienced a remarkable recovery, largely driven by advancements in artificial intelligence and a resurgence in travel demand. Among the standout performers in this landscape, three companies have particularly excelled, showcasing impressive growth potential. Let’s delve...

Continue Reading
Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 58

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
Nebius Group: A Thriving Alternative in AI Computing Sector

Updated Category News Views 453

Nebius Group N.V. Takes on Major Hyperscalers Analyst Alexander Platt from D.A. Davidson & Co. recently launched coverage on Nebius Group N.V. (NASDAQ: NBIS) with a Buy rating, showcasing a promising future as an alternative to leading hyperscalers in the AI computing space. Transforming AI Computing with Transparent Solutions The ever-evolving demand for AI solutions has...

Continue Reading
Innovative Waste Tracking Enhances Hospital Sustainability Efforts

Updated Category News Views 123

Enhancing Hospital Sustainability Through Waste Management In today's driven healthcare landscape, managing waste effectively is more important than ever. remedi, a notable player in the regulated medical waste processing sector, has recently announced an expansion of its waste tracking and reporting capabilities. This initiative aims to assist hospitals in gaining...

Continue Reading
Insights on Core Molding Technologies Stock Movements

Updated Category News Views 148

Core Molding Technologies Stock Activity Overview Recently, there’s been significant trading activity surrounding Core Molding Technologies Inc (NYSEMKT:CMT). Renee R. Anderson, the Executive Vice President of Human Resources, sold shares valued at $32,094. This sale involved 1,783 shares, each priced at $18.00, which caught the attention of both investors and market...

Continue Reading